Studies from 2025 show FAM46C expression sensitizes MM cells to PF-543 cytotoxicity, highlighting its role in sphingolipid metabolism and potential synergy with RNA-based MALAT1 targeting [275], (see Supplementary Tables S1–S4). This evidence concerns the gene MALAT1 and Miyoshi myopathy.